DASETTA 1/35 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dasetta 1/35, and what generic alternatives are available?
Dasetta 1/35 is a drug marketed by Novast Labs Ltd and is included in one NDA.
The generic ingredient in DASETTA 1/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DASETTA 1/35?
- What are the global sales for DASETTA 1/35?
- What is Average Wholesale Price for DASETTA 1/35?
Summary for DASETTA 1/35
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DASETTA 1/35 at DailyMed |
![DASETTA 1/35 drug patent expirations Drug patent expirations by year for DASETTA 1/35](/p/graph/s/t/DASETTA_1/35-patent-expirations.png)
US Patents and Regulatory Information for DASETTA 1/35
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs Ltd | DASETTA 1/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 090948-001 | Dec 22, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |